Key features and details | |
Cat. No. | MABL-3579 |
Name | Anti-SARS-CoV S glycoprotein mabs [11A](MABL-3579) |
Clone No. | 11A |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | NTRL, ELISA |
Species Reactivity | SARSCoronavirus |
Basic Information | |
Specificity | This antibody specifically binds the amino acids 472 and 480 in the S1 domain of the SARS- CoV Spike protein (GD03). |
Alternative Name | Spike protein; S protein; SARS-CoV S protein; S glycoprotein; E2; Peplomer protein; Spike protein S1 |
UniProt | P59594 |
Immunogen | The original antibody was produced by panning against GD03-RBD-C9, two non-immune human Ab phage display libraries and neutralizing activity was tested against pseudotyped viruses. |
Application Notes | This antibody inhibits the association of SARS-CoV S protein to the angiotensin- converting enzyme 2 (ACE2) receptor by binding to specific amino acids on the S1 domain of the spike protein of the virus strain GD03. 11A potently inhibited GD03-RBD’s binding to ACE2 expressing 293T cells. Kinetic analysis of 11A IgG binding to GD03-RBD demonstrated high affinity interaction (KD = 2.260.7 nM). Single amino acid changes at either position D480A or D480G resulted in complete loss of 11A binding. (Sui et al., 2008) |
Antibody First Published | Sui et al. Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog. (2008); 4(11):e1000197.PMID:18989460 |
Note on publication | Describes the methods for generation of a broadly neutralizing antibody by using a combination of chain-shuffling as well as hot-spot CDR mutagenesis. |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |